15. Lu Q,Yang J,Liu Z,et al. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med,2011,184:106-115.
[4]
1. ？Timsit JF,Zahar JR,Chevret S. Attributable mortality of ventilator-associated pneumonia. Curr Opin Crit Care,2011,17:464-471.
[5]
2. Melsen WG,Rovers MM,Groenwold RH,et al. Attributable mortality of ventilator-associated pneumonia:a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis,2013,13:665-671.
[6]
3. Kollef MH,Hamilton CW,Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol,2012,33:250-256.
[7]
4. Sandiumenge A,Rello J. Ventilator-associated pneumonia caused by ESKAPE organisms:cause,clinical features,and management. Curr Opin Pulm Med,2012,18:187-193.
[8]
5. Montgomery AB,Vallance S,Abuan T,et al. A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow？ inline nebulizer system in mechanically ventilated patients. J Aerosol Med Pulm Drug Deliv,2014,27:441-448.
[9]
6. Ryan G,Singh M,Dwan K. Inhaled antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev,2011:CD001021.
[10]
7. Tumbarello M,De Pascale G,Trecarichi EM,et al. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible Gram-negative bacteria. Chest,2013,29:1768-1775.
[11]
8. Kofteridis DP,Alexopoulou C,Valachis A,et al. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia:a matched case-control study. Clin Infect Dis,2010,51:1238-1244.
[12]
9. Rattanaumpawan P,Lorsutthitham J,Ungprasert P,et al. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. J Antimicrob Chemother,2010,65:2645-2649.
11. ATS. Guidelines for the management of adults with hospital-acquired,ventilator-associated,and healthcare-associated pneumonia. Am J Respir Crit Care Med,2005,171:388-416.
